Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection

Thursz, MR; Kwiatkowski, D; Allsopp, C; Hill, B Greenwood AVS; Thomas, HC

doi:10.1042/cs092006Pa

Skip Nav Destination

Article navigation

Conference Abstract| February 01 1997

Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection

MR Thursz;

MR Thursz

1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

D Kwiatkowski;

D Kwiatkowski

1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

C Allsopp;

C Allsopp

1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

B Greenwood AVS Hill;

B Greenwood AVS Hill

1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

HC Thomas

1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1997) 92 (s36): 6P.

https://doi.org/10.1042/cs092006Pa

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Mailing address – 1 Naoroji Street, London WC1X 0GB

Portland Press Tel
+44 (0)20 3880 2795

Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only